2bma
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2bma.gif|left|200px]] | [[Image:2bma.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2bma", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_2bma| PDB=2bma | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTAMATE DEHYDROGENASE, A PUTATIVE TARGET FOR NOVEL ANTIMALARIAL DRUGS''' | '''THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTAMATE DEHYDROGENASE, A PUTATIVE TARGET FOR NOVEL ANTIMALARIAL DRUGS''' | ||
| Line 23: | Line 20: | ||
==Reference== | ==Reference== | ||
The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs., Werner C, Stubbs MT, Krauth-Siegel RL, Klebe G, J Mol Biol. 2005 Jun 10;349(3):597-607. Epub 2005 Apr 12. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15878595 15878595] | The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs., Werner C, Stubbs MT, Krauth-Siegel RL, Klebe G, J Mol Biol. 2005 Jun 10;349(3):597-607. Epub 2005 Apr 12. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15878595 15878595] | ||
| - | [[Category: Glutamate dehydrogenase (NADP(+))]] | ||
[[Category: Plasmodium falciparum]] | [[Category: Plasmodium falciparum]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| Line 30: | Line 26: | ||
[[Category: Stubbs, M T.]] | [[Category: Stubbs, M T.]] | ||
[[Category: Werner, C.]] | [[Category: Werner, C.]] | ||
| - | [[Category: | + | [[Category: Crystal structure analysis]] |
| - | [[Category: | + | [[Category: Drug design]] |
| - | [[Category: | + | [[Category: Glutamate dehydrogenase]] |
| - | [[Category: | + | [[Category: Malaria]] |
| - | [[Category: | + | [[Category: Nadp]] |
| - | [[Category: | + | [[Category: Oligomer organization]] |
| - | [[Category: | + | [[Category: Oxidoreductase]] |
| - | [[Category: | + | [[Category: Plasmodium falciparum]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 20:29:15 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 17:29, 3 May 2008
THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTAMATE DEHYDROGENASE, A PUTATIVE TARGET FOR NOVEL ANTIMALARIAL DRUGS
Overview
Plasmodium falciparum is the main causative agent of tropical malaria, the most severe parasitic disease in the world. Growing resistance of Plasmodia towards available drugs is an increasing problem in countries where malaria is endemic. As Plasmodia are sensitive to oxidative stress, augmenting this in the parasite represents a promising principle for the development of novel antimalarial drugs. The NADP-dependent glutamate dehydrogenase (GDH) of P.falciparum is largely responsible for the production of NADPH in the parasite, which in turn serves as electron source for the antioxidative enzymes glutathione reductase and thioredoxin reductase. As GDH does not occur in the host erythrocyte, GDH is a particularly attractive target for drug therapy. The three-dimensional structure of P.falciparum GDH in the unligated state has been determined by X-ray crystallography to a resolution of 2.7A. Compared to the mammalian enzymes, two amino acid residues are exchanged in the putative active site of the parasite GDH. The most obvious differences between parasite and human GDH are the subunit interfaces of the hexameric proteins. In the parasite protein, several salt-bridges mediate contacts between the subunits whereas in the human enzyme these interactions are mainly of hydrophobic nature. Furthermore, P.falciparum GDH possesses a unique N-terminal extension that does not occur in any other GDH sequence so far studied. These findings might be exploited for the design of peptidomimetics capable of disrupting the oligomeric organisation of the parasite enzyme.
About this Structure
2BMA is a Single protein structure of sequence from Plasmodium falciparum. Full crystallographic information is available from OCA.
Reference
The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs., Werner C, Stubbs MT, Krauth-Siegel RL, Klebe G, J Mol Biol. 2005 Jun 10;349(3):597-607. Epub 2005 Apr 12. PMID:15878595 Page seeded by OCA on Sat May 3 20:29:15 2008
